. 2018 Nov 30;2(6):e160. doi: 10.1097/HS9.0000000000000160
Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.
This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
Figure 2.
Overall survival of the PP set (median follow-up 78 months). PP = per protocol.